These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 9781926

  • 21. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.
    Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F.
    Br J Pharmacol; 1996 Dec; 119(7):1438-46. PubMed ID: 8968553
    [Abstract] [Full Text] [Related]

  • 22. Effect of melatonin and metabolites on copper-mediated oxidation of flow density lipoprotein.
    Seegar H, Mueck AO, Lippert TH.
    Br J Clin Pharmacol; 1997 Sep; 44(3):283-4. PubMed ID: 9296323
    [Abstract] [Full Text] [Related]

  • 23. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach.
    Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U.
    Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914
    [Abstract] [Full Text] [Related]

  • 24. Factors affecting resistance of low density lipoproteins to oxidation.
    Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H.
    Lipids; 1996 Mar; 31 Suppl():S71-6. PubMed ID: 8729097
    [Abstract] [Full Text] [Related]

  • 25. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
    Faure P, Oziol L, Artur Y, Chomard P.
    Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
    [Abstract] [Full Text] [Related]

  • 26. Oxidation decreases low density lipoprotein association with the subendothelium extracellular matrix.
    Savion N, Zavaro O, Kotev-Emeth S.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):497-501. PubMed ID: 9571183
    [Abstract] [Full Text] [Related]

  • 27. Effects of vitamin E on the toxicity of oxidized LDL on endothelial cells in vitro in smokers vs nonsmokers on diets rich in fish.
    Seppo L, Lähteenmäki T, Tikkanen MJ, Vanhanen H, Korpela R, Vapaatalo H.
    Eur J Clin Nutr; 2005 Nov 17; 59(11):1282-90. PubMed ID: 16047029
    [Abstract] [Full Text] [Related]

  • 28. Oxidative modification and antioxidant protection of human low density lipoprotein at high and low oxygen partial pressures.
    Hatta A, Frei B.
    J Lipid Res; 1995 Nov 17; 36(11):2383-93. PubMed ID: 8656076
    [Abstract] [Full Text] [Related]

  • 29. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B.
    Free Radic Biol Med; 1999 Apr 17; 26(7-8):892-904. PubMed ID: 10232833
    [Abstract] [Full Text] [Related]

  • 30. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
    Guyton JR, Lenz ML, Mathews B, Hughes H, Karsan D, Selinger E, Smith CV.
    Atherosclerosis; 1995 Dec 17; 118(2):237-49. PubMed ID: 8770318
    [Abstract] [Full Text] [Related]

  • 31. Oxidized LDL from subjects with different dietary habits modifies atherogenic processes in endothelial and smooth muscle cells.
    Lähteenmäki TA, Seppo L, Laakso J, Korpela R, Vanhanen H, Tikkanen MJ, Vapaatalo H.
    Life Sci; 2000 Dec 17; 66(5):455-65. PubMed ID: 10670834
    [Abstract] [Full Text] [Related]

  • 32. In vitro effects of a flavonoid-rich extract on LDL oxidation.
    Viana M, Barbas C, Bonet B, Bonet MV, Castro M, Fraile MV, Herrera E.
    Atherosclerosis; 1996 Jun 17; 123(1-2):83-91. PubMed ID: 8782839
    [Abstract] [Full Text] [Related]

  • 33. Antioxidant role of melatonin in lipid peroxidation of human LDL.
    Abuja PM, Liebmann P, Hayn M, Schauenstein K, Esterbauer H.
    FEBS Lett; 1997 Aug 18; 413(2):289-93. PubMed ID: 9280299
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions.
    Cominacini L, Garbin U, De Santis A, Campagnola M, Davoli A, Pasini AF, Faccini G, Pasqualini E, Bertozzo L, Micciolo R, Pastorino AM, Lo Cascio V.
    J Lipid Mediat Cell Signal; 1996 Jan 18; 13(1):19-33. PubMed ID: 8821808
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
    Sevanian A, Shen L, Ursini F.
    Pharm Res; 2000 Aug 18; 17(8):999-1006. PubMed ID: 11028948
    [Abstract] [Full Text] [Related]

  • 36. Diphenyl diselenide, a simple glutathione peroxidase mimetic, inhibits human LDL oxidation in vitro.
    de Bem AF, Farina M, Portella Rde L, Nogueira CW, Dinis TC, Laranjinha JA, Almeida LM, Rocha JB.
    Atherosclerosis; 2008 Nov 18; 201(1):92-100. PubMed ID: 18440006
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation.
    Retsky KL, Chen K, Zeind J, Frei B.
    Free Radic Biol Med; 1999 Jan 18; 26(1-2):90-8. PubMed ID: 9890644
    [Abstract] [Full Text] [Related]

  • 38. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
    Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Haji M, Umeda F, Nawata H.
    Endocr J; 1994 Dec 18; 41(6):605-11. PubMed ID: 7704084
    [Abstract] [Full Text] [Related]

  • 39. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions.
    Retsky KL, Freeman MW, Frei B.
    J Biol Chem; 1993 Jan 15; 268(2):1304-9. PubMed ID: 8419332
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.